Evan Wang

Stock Analyst at Guggenheim

(n/a)
# 4,498
Out of 4,784 analysts
7
Total ratings
n/a
Success rate
-58.3%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Evan Wang

Spruce Biosciences
Dec 12, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.30
Upside: -
CureVac
Apr 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Invivyd
Apr 5, 2024
Upgrades: Buy
Price Target: $9
Current: $0.60
Upside: +1,400.00%
Valneva SE
Mar 22, 2024
Maintains: Buy
Price Target: $18$17
Current: $7.26
Upside: +134.16%
Moderna
Apr 26, 2023
Initiates: Neutral
Price Target: n/a
Current: $31.12
Upside: -